Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash Flows from Operating Activities:    
Net Loss $ (4,363,567) $ (2,421,938)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of Film and Television Costs 158,168 0
Depreciation Expense 49,637 46,501
Amortization Expense 57,763 50,322
Imputed Interest Expense 6,141 18,544
Bad Debt Expense / (Recovery) 0 (1,550)
Stock Issued for Services 39,000 0
Stock Compensation Expense 1,236,880 0
(Gain) Loss on Distribution Contracts (258,103) (102,350)
(Gain) Loss on Impairment of Assets 1,850 7,500
(Gain) Loss on Deferred Financing Asset 0 9,313
(Gain) Loss on Foreign Currency Translation 0 36,258
Decrease (increase) in operating assets    
Accounts Receivable 220,285 18,612
Inventory 518 (2,355)
Prepaid Expenses & Other Assets (253,678) 16,744
Film and Television Costs, net (754,770) (599,681)
Increase (decrease) in operating liabilities    
Accounts Payable 66,247 (14,059)
Accrued Salaries 23,223 35,332
Deferred Revenue and Advances 2,159,120 165,270
Other Accrued Expenses (274,042) 125,930
Net cash used in operating activities (1,885,328) (2,611,607)
Cash Flows from Investing Activities:    
Investment in Intangible Assets (5,650) (111,221)
Investment in Fixed Assets (1,542) (180,853)
Net cash used in investing activities (7,192) (292,074)
Cash Flows from Financing Activities:    
Proceeds from Exercise of Warrants 110,000 0
Proceeds from Production Facility, Net of Offering Costs 237,567 0
Proceeds from Services Advance 0 750,000
Proceeds of Related Party Notes 0 513
Net cash provided by financing activities 347,567 750,513
Net Decrease in Cash and Cash Equivalents (1,544,953) (2,153,168)
Beginning Cash and Cash Equivalents 5,187,620 4,301,099
Ending Cash and Cash Equivalents 3,642,667 2,147,931
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 1,450 1,076
Schedule of non-cash financing and investing activites:    
Issuance Of Common Stock In Satisfaction Of Short Term Advances $ 410,535 $ 0